Top Clinical Trials companies in Sweden by Free Cash Flow Yield

This ranking features the top 61 Clinical Trials companies in Sweden ranked by Free Cash Flow Yield, averaging a Free Cash Flow Yield of -17.19%, for July 09, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in Sweden has the highest Free Cash Flow Yield ?

The Clinical Trials company in Sweden with the highest Free Cash Flow Yield is Sleep Cycle AB (publ) (Stockholm Stock Exchange: SLEEP.ST) at 8.26%.

Which Clinical Trials company in Sweden has the lowest Free Cash Flow Yield ?

The Clinical Trials company in Sweden with the lowest Free Cash Flow Yield is Lipum AB (publ) (Stockholm Stock Exchange: LIPUM.ST) at None.

What are the top 10 Clinical Trials companies in Sweden by Free Cash Flow Yield ?

The top 10 Clinical Trials companies in Sweden by Free Cash Flow Yield are Sleep Cycle AB (publ), Arjo AB (publ), ContextVision AB (publ), Vitrolife AB (publ), Swedish Orphan Biovitrum AB (publ), CellaVision AB (publ), Vimian Group AB (publ), RaySearch Laboratories AB (publ), C-Rad AB (publ) and Surgical Science Sweden AB (publ).

What are the bottom 10 Clinical Trials companies in Sweden by Free Cash Flow Yield ?

The bottom 10 Clinical Trials companies in Sweden by Free Cash Flow Yield are Lipum AB (publ), Guard Therapeutics International AB (publ), Kancera AB (publ), Elicera Therapeutics AB (publ), BioArctic AB (publ), Genovis AB (publ.), Infant Bacterial Therapeutics AB (publ), Elekta AB (publ), Aptahem AB (publ) and Modus Therapeutics Holding AB (publ).